Recombinant human endostatin-associated acute left heart failure.
Jing
Q
Q
Xinyu
Q
Q
Rougcheng
L
L
D000208:Acute Disease; D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004417:Dyspnea / Q000139:chemically induced; D043169:Endostatins / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000187:drug effects; D011994:Recombinant Proteins / Q000009:adverse effects; D000093542:Gemcitabine
D000970:Antineoplastic Agents; D003841:Deoxycytidine; D043169:Endostatins; D018719:Erb-b2 Receptor Tyrosine Kinases; D011994:Recombinant Proteins; D000093542:Gemcitabine